Abstracts tagged "Metabolic syndrome and psoriatic arthritis"

Abstract Number: 1716 • 2016 ACR/ARHP Annual Meeting
Higher Frequency and Severity of Coronary Plaques on Coronary CT Angiography in Psoriatic Arthritis Patients without Symptoms of Coronary Artery Disease Compared to Controls
Agnes Szentpetery¹, Darragh Brady², Gerard Healy², Ciaran Redmond², Hannah Fleming², John Duignan², Muhammad Haroon¹, Jonathan Dodd² and Oliver FitzGerald³, ¹St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, ²St. Vincent's University Hospital, Department of Radiology, Dublin, Ireland, ³St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
Background/Purpose: Patients with psoriasis (PsO) and psoriatic arthritis (PsA) have an increased prevalence of cardiovascular (CV) risk factors, metabolic syndrome (Metsy), and higher risk…
Abstract Number: 1685 • 2015 ACR/ARHP Annual Meeting
Metabolic Syndrome in Patients with Psoriatic Arthritis Is Associated to Peripheral Disease Activity
Camilla De Gaspari^1,2, Julio C. B. Moraes^3,4, Percival D Sampaio-Barros^5,6, Celio R. Gonçalves⁷, Carla G.S. Saad⁸ and Cláudia Goldenstein-Schainberg⁹, ¹Rheumatology Division, University of Sao Paulo, São Paulo, Brazil, ²Rheumatology, Universidade de São Paulo, São Paulo, Brazil, ³Rheumatology, Faculdade de Medicina Universidade de São Paulo, São Paulo, Brazil, ⁴Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo., Jundiai, Brazil, ⁵Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁶Faculdade de Medicina da Universidade de São Paulo, Rheumatology Division, Brazil, Sao Paulo, Brazil, ⁷Reumatologia, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ⁸Rheumatology Division, Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, ⁹Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
Background/Purpose: Psoriatic arthritis (PsA) is present in about 30% of cutaneous psoriasis (PsO) patients. Both PsO and PsA are frequently associated to comorbidities that have…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].